3 Reasons to Buy Allergan plc Stock Right Now
Allergan (NYSE: AGN) is one of the most underappreciated big pharma stocks on the market right now. That's the thought that occurred to me as I listened to Brent Saunders, Allergan's CEO, speak at the Wells Fargo Healthcare Conference on Thursday.
One thing's for sure, though: Underappreciated stocks don't stay that way for too long. Investors eventually begin to see the value in the stock, interest increases, and the stock moves higher. I think that's going to happen with Allergan. Here are three top reasons investors should consider buying this big pharma stock right now.
Image source: Getty Images.
Source: Fool.com
Teva Pharmaceutical Industries Ltd ADR Stock
€15.60
-1.270%
With 17 Buy predictions and not the single Sell prediction the community is currently very high on Teva Pharmaceutical Industries Ltd ADR.
With a target price of 18 € there is a slightly positive potential of 15.38% for Teva Pharmaceutical Industries Ltd ADR compared to the current price of 15.6 €.
